15 January 2002
Extended-spectrum beta-lactamase-producing Enterobacteriaceae strains in community-acquiredbacteremia in Southern Israel.
Nechama Peled, Jacob Gilad, Galia Menashe, Abraham Borer, Klaris Riesenberg, Francisc SchlaefferMed Sci Monit 2002; 8(1): CR44-47 :: ID: 420952
Abstract
BACKGROUND: In recent years, extended-spectrum beta-lactamase (ESBL)-producingEnterobacteriaceae have emerged in many hospitals worldwide. The increasing dissemination and long-termcarriage of these organisms within the community carry tremendous implications on the empirical therapyof community-acquired infection. MATERIAL/METHODS: To evaluate the prevalence and clinical features ofcommunity-acquired bacteremia involving ESBL-producing Enterobacteriaceae in southern Israel (ESBL-P)we retrospectively studied all Enterobacteriaceae bacteremias during an 8-month period in the Negev regionusing medical and laboratory records. Antibiotic susceptibility was determined using the disk-diffusionmethod. ESBL production was determined using an E-test ESBL strip. Cases involving ESBL-P were comparedto those involving non-producing strains (ESBL-NP) using the chi-square test. RESULTS: In all, 187 Enterobacteriaceaebacteremias were detected, of which 119 were community-acquired (63.6%). ESBL-P were found in six cases(5%) which are described herein in greater detail. Patients with ESBL-P bacteremia were older, and weremore likely to stay in the intensive-care unit. Urinary catheterization and bed-ridden conditions weresignificant risk factors for ESBL-P. ESBL-P strains were significantly resistant to nearly all antibioticagents except for imipienem and piperacillin-tazobactam as opposing to ESBL-NP. Patients with ESBL-Pbacteremia were more likely to suffer from complications and had a higher mortality. CONCLUSIONS: Thispaper is the first to describe community-acquired Enterobacteriaceae bacteremia involving ESBL-P strainsin Israel. Although the exact prevalence of these organisms in Israel is currently unknown, our findingssuggest that ESBL-producers have already begun to disseminate in our community.
Keywords: Aged, 80 and over, Community-Acquired Infections, Enterobacteriaceae, Enterobacteriaceae Infections, Israel, beta-Lactamases
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952